Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapaglifozin in Type 2 Diabetes Mellitus Patients: A Single-centre Retrospective Cohort Study

NCT02966626 is registered in ClinicalTrials.gov with University of Malaya as lead sponsor.

NCT NCT02966626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02966626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapaglifozin in Type 2 Diabetes Mellitus Patients: A Single-centre Retrospective Cohort Study
Lead sponsor
University of Malaya
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
January 31, 2018
Enrollment
223 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes